Leitersdorf E - Search Results

1

Plasma lipids and lipoproteins response to a dietary challenge: analysis of four candidate genes.

Friedlander Y, Berry EM, Eisenberg S, Stein Y, Leitersdorf E. Friedlander Y, et al. Among authors: leitersdorf e. Clin Genet. 1995 Jan;47(1):1-12. doi: 10.1111/j.1399-0004.1995.tb03913.x. Clin Genet. 1995. PMID: 7774036 Clinical Trial.

2

Diverse effect of ethnicity on plasma lipoprotein[a] levels in heterozygote patients with familial hypercholesterolemia.

Leitersdorf E, Friedlander Y, Bard JM, Fruchart JC, Eisenberg S, Stein Y. Leitersdorf E, et al. J Lipid Res. 1991 Sep;32(9):1513-9. J Lipid Res. 1991. PMID: 1836489 Free article.

3

Segregation analysis of plasma lipoprotein(a) levels in pedigrees with molecularly defined familial hypercholesterolemia.

Friedlander Y, Leitersdorf E. Friedlander Y, et al. Among authors: leitersdorf e. Genet Epidemiol. 1995;12(2):129-43. doi: 10.1002/gepi.1370120203. Genet Epidemiol. 1995. PMID: 7607414

4

Influence of apolipoprotein E genotypes on plasma lipid and lipoprotein concentrations: results from a segregation analysis in pedigrees with molecularly defined familial hypercholesterolemia.

Friedlander Y, Leitersdorf E. Friedlander Y, et al. Among authors: leitersdorf e. Genet Epidemiol. 1996;13(2):159-77. doi: 10.1002/(SICI)1098-2272(1996)13:2<159::AID-GEPI3>3.0.CO;2-3. Genet Epidemiol. 1996. PMID: 8722744

5

The contribution of candidate genes to the response of plasma lipids and lipoproteins to dietary challenge.

Friedlander Y, Leitersdorf E, Vecsler R, Funke H, Kark J. Friedlander Y, et al. Among authors: leitersdorf e. Atherosclerosis. 2000 Sep;152(1):239-48. doi: 10.1016/s0021-9150(99)00474-8. Atherosclerosis. 2000. PMID: 10996360 Clinical Trial.

6

Hypercholesterolemia in five Israeli Christian-Arab kindreds is caused by the "Lebanese" allele at the low density lipoprotein receptor gene locus and by an additional independent major factor.

Oppenheim A, Friedlander Y, Dann EJ, Berkman N, Schwartz SP, Leitersdorf E. Oppenheim A, et al. Among authors: leitersdorf e. Hum Genet. 1991 Nov;88(1):75-84. doi: 10.1007/BF00204933. Hum Genet. 1991. PMID: 1959928

7

Cerebrotendinous xanthomatosis in the Israeli Druze: molecular genetics and phenotypic characteristics.

Leitersdorf E, Safadi R, Meiner V, Reshef A, Björkhem I, Friedlander Y, Morkos S, Berginer VM. Leitersdorf E, et al. Am J Hum Genet. 1994 Nov;55(5):907-15. Am J Hum Genet. 1994. PMID: 7977352 Free PMC article.

8

Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia.

Leitersdorf E, Eisenberg S, Eliav O, Friedlander Y, Berkman N, Dann EJ, Landsberger D, Sehayek E, Meiner V, Wurm M, et al. Leitersdorf E, et al. Circulation. 1993 Apr;87(4 Suppl):III35-44. Circulation. 1993. PMID: 8462179 Clinical Trial.

9

The modulation of plasma lipids and lipoproteins during bone marrow transplantation is unrelated to exogenously administered recombinant human granulocyte-monocyte colony-stimulating factor (rHu GM-CSF).

Dann EJ, Friedlander Y, Leitersdorf E, Nagler A. Dann EJ, et al. Among authors: leitersdorf e. Med Oncol. 1996 Jun;13(2):81-6. doi: 10.1007/BF02993857. Med Oncol. 1996. PMID: 9013470 Clinical Trial.

10

Taq1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol.

Kark JD, Sinnreich R, Leitersdorf E, Friedlander Y, Shpitzen S, Luc G. Kark JD, et al. Among authors: leitersdorf e. Atherosclerosis. 2000 Aug;151(2):509-18. doi: 10.1016/s0021-9150(99)00408-6. Atherosclerosis. 2000. PMID: 10924728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters